
("
Half Year Trading Update: Strategic progress and a strong H1
Group revenue for H1 FY26 is expected to be approximately
At the time of our IPO in 2021,
Over the period, we have significantly enhanced our corporate client base, with a particular focus on adding high-quality mid-cap and growth companies. Our
Our strategy to diversify beyond our core ECM business, acting as a trusted advisor to our clients, has delivered strong results. In H1 FY26, we acted as lead financial advisor on 11 M&A transactions with a total deal value of
We have continued to invest in our distribution capabilities, particularly internationally. In addition to our
Our ambition to enhance competitiveness through technology has also yielded strong results. Execution Services delivered its best half-year performance since the record-breaking Covid lockdown period, despite increased market competition.
Earlier this year, the Board made a strategic decision to refocus the business on delivering sustainable profitability through the economic cycle. This included a reduction in fixed costs, alongside a commitment to continue investing in our client service capabilities. As a result of these changes, our strong revenue performance is now supported by a leaner and better aligned cost base, which we expect to be reflected in the profitability of the Group over this financial year.
Outlook
Following the typically quieter summer holiday period, trading activity resumed in September. Our Investment Banking pipeline remains healthy, benefitting from several announced transactions expected to complete in the second half of the financial year. While ECM activity, including IPOs, is beginning to emerge, transactions continue to be weighted towards M&A. Despite the ongoing economic and geopolitical uncertainty, we remain optimistic about our performance for the remainder of the year.
For further information, please contact:
Sodali & Co (Financial PR): +44 (0)20 7100 6451
peelhunt@sodali.com
Notes to editors
About
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the